Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diabetes Center Berne (DCB) is a Swiss innovation and research hub focused on translating diabetes technology from basic research into clinical practice. It supports over 100 start-ups globally, runs an annual Open Innovation Challenge for diabetes tech, and directly conducts or sponsors early-stage clinical trials of novel glucose monitoring and therapeutic devices, including non-invasive sensors and AI-driven platforms. DCB’s mission is to improve the lives of people with diabetes by advancing diabetes technology, reducing healthcare costs, and fostering a vibrant, international innovation ecosystem[1][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diabetes Center Berne.